Related references
Note: Only part of the references are listed.The Pharmacogene Variation (PharmVar) Consortium: Incorporation of the Human Cytochrome P450 (CYP) Allele Nomenclature Database
Andrea Gaedigk et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2018)
Challenges for achieving safe and effective radical cure of Plasmodium vivax: a round table discussion of the APMEN Vivax Working Group
Kamala Thriemer et al.
MALARIA JOURNAL (2017)
Burden and impact of Plasmodium vivax in pregnancy: A multi-centre prospective observational study
Azucena Bardaj et al.
PLOS NEGLECTED TROPICAL DISEASES (2017)
Characterisation of the opposing effects of G6PD deficiency on cerebral malaria and severe malarial anaemia
Geraldine M. Clarke et al.
ELIFE (2017)
Global Epidemiology of Plasmodium vivax
Rosalind E. Howes et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2016)
National, regional, and worldwide estimates of stillbirth rates in 2015, with trends from 2000: a systematic analysis
Hannah Blencowe et al.
LANCET GLOBAL HEALTH (2016)
Targeting vivax malaria in the Asia Pacific: The Asia Pacific Malaria Elimination Network Vivax Working Group
Nicholas M. Anstey et al.
MALARIA JOURNAL (2015)
Randomized, Open-Label Trial of Primaquine against Vivax Malaria Relapse in Indonesia
Inge Sutanto et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
Review of key knowledge gaps in glucose-6-phosphate dehydrogenase deficiency detection with regard to the safe clinical deployment of 8-aminoquinoline treatment regimens: a workshop report
Lorenz von Seidlein et al.
MALARIA JOURNAL (2013)
Primaquine Failure and Cytochrome P-450 2D6 in Plasmodium vivax Malaria
Jason W. Bennett et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
G6PD Deficiency Prevalence and Estimates of Affected Populations in Malaria Endemic Countries: A Geostatistical Model-Based Map
Rosalind E. Howes et al.
PLOS MEDICINE (2012)
Pharmacogenetic variation at CYP2C9, CYP2C19, and CYP2D6 at global and microgeographic scales
Johanna Sistonen et al.
PHARMACOGENETICS AND GENOMICS (2009)
The CYP2D6 activity score: Translating genotype information into a qualitative measure of phenotype
A. Gaedigk et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2008)
Cytochrome P450 2D6: overview and update on pharmacology, genetics, biochemistry
UM Zanger et al.
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2004)
Unique CYP2D6 activity distribution and genotype-phenotype discordance in black Americans
A Gaedigk et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2002)
Share Paper
